JP2025514636A5 - - Google Patents
Info
- Publication number
- JP2025514636A5 JP2025514636A5 JP2024558241A JP2024558241A JP2025514636A5 JP 2025514636 A5 JP2025514636 A5 JP 2025514636A5 JP 2024558241 A JP2024558241 A JP 2024558241A JP 2024558241 A JP2024558241 A JP 2024558241A JP 2025514636 A5 JP2025514636 A5 JP 2025514636A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- seq
- antigen
- binding fragment
- sequence shown
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210343364 | 2022-04-02 | ||
| CN202210345737.1 | 2022-04-02 | ||
| CN202210343364.4 | 2022-04-02 | ||
| CN202210345737 | 2022-04-02 | ||
| PCT/CN2023/085460 WO2023186092A1 (zh) | 2022-04-02 | 2023-03-31 | 针对c-Met的单克隆抗体以及双特异性抗体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025514636A JP2025514636A (ja) | 2025-05-09 |
| JP2025514636A5 true JP2025514636A5 (https=) | 2025-08-07 |
Family
ID=88199447
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024558241A Pending JP2025514636A (ja) | 2022-04-02 | 2023-03-31 | ｃ－Ｍｅｔに対するモノクローナル抗体及び二重特異性抗体 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250223366A1 (https=) |
| EP (1) | EP4506363A1 (https=) |
| JP (1) | JP2025514636A (https=) |
| KR (1) | KR20240168447A (https=) |
| CN (1) | CN119013296A (https=) |
| AU (1) | AU2023247654A1 (https=) |
| CL (1) | CL2024002974A1 (https=) |
| IL (1) | IL315910A (https=) |
| MX (1) | MX2024012143A (https=) |
| WO (1) | WO2023186092A1 (https=) |
| ZA (1) | ZA202408262B (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025146619A1 (ko) * | 2024-01-02 | 2025-07-10 | 주식회사 종근당 | 항 c-met 항체를 포함하는 항암 조합물 |
| WO2025185602A1 (en) * | 2024-03-05 | 2025-09-12 | Hansoh Bio Llc | Immunoconjugates and pharmaceutical uses thereof |
| TW202540193A (zh) * | 2024-03-14 | 2025-10-16 | 大陸商珠海普米斯生物科技有限公司 | 雙特異性抗體、抗體藥物偶聯物及其應用 |
| WO2025247330A1 (zh) * | 2024-05-31 | 2025-12-04 | 江苏先声生物制药有限公司 | 抗EGFR×cMet双特异性抗体的药物偶联物及其用途 |
| CN121045385B (zh) * | 2025-11-03 | 2026-02-10 | 广州安必平医药科技股份有限公司 | 一种抗c-met蛋白单克隆抗体及其相关产品和用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| CA2450285C (en) | 2001-06-13 | 2016-08-02 | Genmab A/S | Human monoclonal antibodies to epidermal growth factor receptor (egfr) |
| HN2004000285A (es) * | 2003-08-04 | 2006-04-27 | Pfizer Prod Inc | ANTICUERPOS DIRIGIDOS A c-MET |
| US8101727B2 (en) * | 2006-03-30 | 2012-01-24 | Novartis Ag | Compositions and methods of use for antibodies of c-Met |
| PT3904391T (pt) | 2010-03-10 | 2024-10-14 | Genmab As | Anticorpos monoclonais contra c-met |
| JP7325339B2 (ja) * | 2017-05-30 | 2023-08-14 | チョン クン ダン ファーマシューティカル コーポレーション | 新規な抗ｃ－Ｍｅｔ抗体およびその用途 |
| CN120383671A (zh) | 2019-09-30 | 2025-07-29 | 阿迪马布有限责任公司 | 被工程化用于优先轻链配对的ch1结构域变体和包括所述ch1结构域变体的多特异性抗体 |
-
2023
- 2023-03-31 WO PCT/CN2023/085460 patent/WO2023186092A1/zh not_active Ceased
- 2023-03-31 EP EP23778456.6A patent/EP4506363A1/en active Pending
- 2023-03-31 CN CN202380031276.3A patent/CN119013296A/zh active Pending
- 2023-03-31 AU AU2023247654A patent/AU2023247654A1/en active Pending
- 2023-03-31 KR KR1020247036568A patent/KR20240168447A/ko active Pending
- 2023-03-31 US US18/852,602 patent/US20250223366A1/en active Pending
- 2023-03-31 IL IL315910A patent/IL315910A/en unknown
- 2023-03-31 JP JP2024558241A patent/JP2025514636A/ja active Pending
-
2024
- 2024-09-30 MX MX2024012143A patent/MX2024012143A/es unknown
- 2024-10-02 CL CL2024002974A patent/CL2024002974A1/es unknown
- 2024-10-31 ZA ZA2024/08262A patent/ZA202408262B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025514636A5 (https=) | ||
| JP7502549B2 (ja) | 抗体－薬物コンジュゲートの薬物部位を認識する蛋白質 | |
| CN115551889A (zh) | 抗cd73抗体及其用途 | |
| JP2022535553A5 (https=) | ||
| EP3180356B1 (en) | Human anti-fgfr4 antibody | |
| JP7094893B2 (ja) | エンドシアリン結合抗体 | |
| KR102580319B1 (ko) | 항 ceacam6 항체 및 사용 방법 | |
| JP2023527937A5 (https=) | ||
| JP2025512119A5 (https=) | ||
| CN111278992A (zh) | 用抗egfr抗体治疗癌症的组合物和方法 | |
| JP2024532836A5 (https=) | ||
| JP2025513930A5 (https=) | ||
| JP2022502079A5 (https=) | ||
| JP2025525408A (ja) | 二重特異性抗体及びその応用 | |
| JP2024533993A5 (https=) | ||
| RU2707121C9 (ru) | АНТИТЕЛО, СПЕЦИФИЧЕСКИ СВЯЗЫВАЮЩЕЕСЯ С ErbB3, И ЕГО ПРИМЕНЕНИЕ | |
| JP2025513767A5 (https=) | ||
| CN114616245B (zh) | 一种抗cd38的抗体及其用途 | |
| JP2024508597A5 (https=) | ||
| JP2024502670A5 (https=) | ||
| WO2025239422A1 (ja) | コートマータンパク質複合体サブユニットベータ２に対する抗体 | |
| HK40083261A (en) | Anti-cd73 antibody and use thereof | |
| KR20250169623A (ko) | 암 치료를 위한 grem1 길항제를 수반하는 조합 요법 | |
| NZ783695B2 (en) | Binding molecule specific for cd73 and use of binding molecule | |
| RU2022107092A (ru) | Новые анти-cldn18.2 антитела |